Literature DB >> 30878815

What are the best indicators to assess malnutrition in idiopathic pulmonary fibrosis patients? A cross-sectional study in a referral center.

Stéphane Jouneau1, Mallorie Kerjouan2, Chloé Rousseau3, Mathieu Lederlin4, Francisco Llamas-Guttierez5, Bertrand De Latour6, Stéphanie Guillot7, Laurent Vernhet8, Benoit Desrues9, Ronan Thibault10.   

Abstract

OBJECTIVES: Little is known about the indicators to assess malnutrition in patients with idiopathic pulmonary fibrosis (IPF). This study aimed to determine the following: 1) the prevalence of malnutrition in IPF patients; 2) the nutritional indicators predictive of low fat-free mass (FFM) as measured by bioimpedance analysis; 3) the IPF patients' characteristics associated with low FFM.
METHODS: The IPF patients were consecutively recruited in a referral center for rare pulmonary diseases. Malnutrition was defined as a fat-free mass index (FFMI) = FFM (kg) / (height [m]2) <17 (men) or <15 (women). Nutritional assessment included body mass index (BMI), mid-arm circumference (MAC), triceps skinfold thickness, analogue food intake scale, and serum albumin and transthyretin. The primary endpoint was FFMI. Area under the receiver operating characteristic curve (AUC) assessed low FFMI prediction from nutritional indicators. Multivariable logistic regression determined variables associated with low FFMI.
RESULTS: Eighty-one patients were consecutively recruited. Low FFMI prevalence was 28% (23 of 81). BMI AUC was 0.91 (95% confidence interval [CI], 0.84‒0.97) and MAC AUC was 0.85 (0.76‒0.94). Multivariable analysis associated BMI (odds ratio [OR] 0.26 [95% CI, 0.12-0.54], P = 0.0003), male sex (OR 0.02 [0.00-0.33], P = 0.005), and smoking (OR 0.10 [0.01-0.75], P = 0.024) with a lower risk of malnutrition.
CONCLUSIONS: Malnutrition occurred in nearly one-third of IPF patients. Malnutrition screening should become systematic based on BMI and MAC, which are good clinical indicators of low FFMI. We propose a practical approach to screen malnutrition in IPF patients.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bioelectrical impedance analysis; Food intake; Interstitial lung disease; Lean body mass; Malnutrition

Year:  2018        PMID: 30878815     DOI: 10.1016/j.nut.2018.12.008

Source DB:  PubMed          Journal:  Nutrition        ISSN: 0899-9007            Impact factor:   4.008


  9 in total

1.  High Prevalence of Nutritional Risk Among Pulmonary Patients Living on the Tibetan Plateau.

Authors:  Chilie Quncuo; Ying Liang; Qiuyu Li; Xiaoli She; Bian Ma Cuo; Bianba Qiongda; Meilang ChuTso; Yongchang Sun
Journal:  Front Nutr       Date:  2022-05-10

2.  Idiopathic pulmonary fibrosis cluster analysis highlights diagnostic delay and cardiovascular comorbidity association with outcome.

Authors:  Jaume Bordas-Martínez; Ricard Gavaldà; Jessica G Shull; Vanesa Vicens-Zygmunt; Lurdes Planas-Cerezales; Guadalupe Bermudo-Peloche; Salud Santos; Neus Salord; Carmen Monasterio; Maria Molina-Molina; Guillermo Suarez-Cuartin
Journal:  ERJ Open Res       Date:  2021-05-10

Review 3.  Nutrition in Patients with Idiopathic Pulmonary Fibrosis: Critical Issues Analysis and Future Research Directions.

Authors:  Paola Faverio; Marialuisa Bocchino; Antonella Caminati; Alessia Fumagalli; Monica Gasbarra; Paola Iovino; Alessandra Petruzzi; Luca Scalfi; Alfredo Sebastiani; Anna Agnese Stanziola; Alessandro Sanduzzi
Journal:  Nutrients       Date:  2020-04-17       Impact factor: 5.717

Review 4.  Idiopathic pulmonary fibrosis beyond the lung: understanding disease mechanisms to improve diagnosis and management.

Authors:  Fabrizio Luppi; Meena Kalluri; Paola Faverio; Michael Kreuter; Giovanni Ferrara
Journal:  Respir Res       Date:  2021-04-17

5.  Nutritional assessment in idiopathic pulmonary fibrosis: a prospective multicentre study.

Authors:  Paola Faverio; Alessia Fumagalli; Sara Conti; Fabiana Madotto; Francesco Bini; Sergio Harari; Michele Mondoni; Tiberio Oggionni; Emanuela Barisione; Paolo Ceruti; Maria Chiara Papetti; Bruno Dino Bodini; Antonella Caminati; Angela Valentino; Stefano Centanni; Donatella Noè; Matteo Della Zoppa; Silvia Crotti; Marco Grosso; Samir Giuseppe Sukkar; Denise Modina; Marco Andreoli; Roberta Nicali; Giulia Suigo; Federica De Giacomi; Sara Busnelli; Elena Cattaneo; Lorenzo Giovanni Mantovani; Giancarlo Cesana; Alberto Pesci; Fabrizio Luppi
Journal:  ERJ Open Res       Date:  2022-03-07

6.  Impact of sarcopenia on chemotherapy-triggered exacerbation of interstitial lung disease in patients with non-small cell lung cancer.

Authors:  Ryota Kikuchi; Hiroyuki Takoi; Mayuko Ishiwari; Kazutoshi Toriyama; Yuta Kono; Yuki Togashi; Shinji Abe
Journal:  Thorac Cancer       Date:  2021-12-28       Impact factor: 3.500

7.  Impact of body weight change on clinical outcomes in patients with idiopathic pulmonary fibrosis receiving pirfenidone.

Authors:  Tae Hun Kim; Yune-Young Shin; Hyung-Jun Kim; Myung Jin Song; Yeon Wook Kim; Sung Yoon Lim; Yeon Joo Lee; Jong Sun Park; Young-Jae Cho; Jae Ho Lee; Choon-Taek Lee; Byoung Soo Kwon
Journal:  Sci Rep       Date:  2022-10-17       Impact factor: 4.996

8.  Body mass index and in-hospital mortality in patients with acute exacerbation of idiopathic pulmonary fibrosis.

Authors:  Nobuyasu Awano; Taisuke Jo; Hideo Yasunaga; Minoru Inomata; Naoyuki Kuse; Mari Tone; Kojiro Morita; Hiroki Matsui; Kiyohide Fushimi; Takahide Nagase; Takehiro Izumo
Journal:  ERJ Open Res       Date:  2021-06-28

9.  Nutritional Risk Screening Tools for Older Adults with COVID-19: A Systematic Review.

Authors:  David Franciole Oliveira Silva; Severina Carla Vieira Cunha Lima; Karine Cavalcanti Mauricio Sena-Evangelista; Dirce Maria Marchioni; Ricardo Ney Cobucci; Fábia Barbosa de Andrade
Journal:  Nutrients       Date:  2020-09-27       Impact factor: 5.717

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.